Paxlovid contract renegotiation pushed Covid business over the edge, says BMO's Evan Seigerman
Evan Seigerman, BMO Capital Markets analyst, joins 'Closing Bell: Overtime' to discuss Pfizer and BioNTech cutting guidance amid Covid sales falling, the weight loss boom, and more.
Видео Paxlovid contract renegotiation pushed Covid business over the edge, says BMO's Evan Seigerman канала CNBC Television
Видео Paxlovid contract renegotiation pushed Covid business over the edge, says BMO's Evan Seigerman канала CNBC Television
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
Veterans: Next battleLightning Round: Vertiv is 'hitting it out of the park', says Jim CramerJim Cramer explains why he favors Eli Lilly in the weight loss drug spaceJim Cramer weighs the market impact of Eli Lilly and Novo Nordisk's weight loss drugsJim Cramer covers the market's 'Wall of Worry'The bond market might be the most ferocious brick in the Wall of Worry, says Jim CramerHow Novo Nordisk's ‘select’ study results could shake up the obesity drug spaceChart Master: What's next for Walmart and TargetOptions Action: Traders feeling bullish toward LucidInvestors should stay in the markets but err on the side of defensiveness, says Adam HettsThe Fed will continue to overtighten, says Charles Schwab's Kevin GordonBiden and Xi's upcoming meeting is about 'setting a tone', says Blueshirt's Gary DvorchakNvidia is a must own in the AI race, says Bernstein's Stacy RasgonNo reason the S&P 500 can't continue to rally through end of the year, says Solus' Dan GreenhausETF Edge, November 13, 2023State of value investing in 2024ETF SIZZLE FOR SOCIALThe "active" arena suddenly gets crowdedHome builders are in a secular run, says Strategas' Chris VerroneCantor's Eric Johnston on economy: Outlook is deterioratingLIVE: White House press secretary Karine Jean-Pierre holds a briefing with reporters — 11/13/23